MA55958A - Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida auris - Google Patents
Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida aurisInfo
- Publication number
- MA55958A MA55958A MA055958A MA55958A MA55958A MA 55958 A MA55958 A MA 55958A MA 055958 A MA055958 A MA 055958A MA 55958 A MA55958 A MA 55958A MA 55958 A MA55958 A MA 55958A
- Authority
- MA
- Morocco
- Prior art keywords
- ibrexafungerp
- decolonization
- antifungal agents
- candida auris
- auris
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962849019P | 2019-05-16 | 2019-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA55958A true MA55958A (fr) | 2022-03-23 |
Family
ID=70861571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA055958A MA55958A (fr) | 2019-05-16 | 2020-05-12 | Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida auris |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220211684A1 (fr) |
| EP (1) | EP3968986A1 (fr) |
| JP (1) | JP2022532734A (fr) |
| KR (1) | KR20220009416A (fr) |
| CN (1) | CN113905733A (fr) |
| AU (1) | AU2020276595A1 (fr) |
| BR (1) | BR112021022876A2 (fr) |
| CA (1) | CA3140637A1 (fr) |
| EA (1) | EA202193146A1 (fr) |
| IL (1) | IL288165A (fr) |
| MA (1) | MA55958A (fr) |
| MX (1) | MX2021013899A (fr) |
| TW (1) | TW202110441A (fr) |
| WO (1) | WO2020232037A1 (fr) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| WO2007126900A2 (fr) | 2006-04-03 | 2007-11-08 | Merck & Co., Inc. | Agents antifongiques |
| CA2731941C (fr) | 2008-08-12 | 2016-09-27 | Merck Sharp & Dohme Corp. | Derives d'enfumafungine comme inhibiteurs de (1,3)-beta.-d-glucane synthase |
| MY156955A (en) * | 2008-08-12 | 2016-04-15 | Scynexis Inc | Antifungal agents |
| MA43825A (fr) * | 2016-03-16 | 2021-04-07 | Cidara Therapeutics Inc | Schémas posologiques pour le traitement d'infections fongiques |
| AU2018253031B2 (en) * | 2017-04-10 | 2024-04-11 | Scynexis, Inc. | Antifungal agents used in combination |
| EP3625360A4 (fr) * | 2017-05-17 | 2021-03-24 | T2 Biosystems, Inc. | Méthodes et systèmes de rmn pour une détection rapide d'espèces de candida |
| HUE060508T2 (hu) * | 2017-08-04 | 2023-03-28 | Scynexis Inc | Savas pH-n fokozott aktivitású antifungális szerek |
| JP7562542B2 (ja) * | 2019-01-30 | 2024-10-07 | サイネクシス，インコーポレーテッド | 真菌性骨－関節感染症を治療するためのトリテルペノイド系抗真菌薬 |
-
2020
- 2020-05-12 JP JP2021568113A patent/JP2022532734A/ja active Pending
- 2020-05-12 US US17/610,440 patent/US20220211684A1/en active Pending
- 2020-05-12 MX MX2021013899A patent/MX2021013899A/es unknown
- 2020-05-12 CN CN202080041224.0A patent/CN113905733A/zh active Pending
- 2020-05-12 AU AU2020276595A patent/AU2020276595A1/en active Pending
- 2020-05-12 WO PCT/US2020/032547 patent/WO2020232037A1/fr active Application Filing
- 2020-05-12 KR KR1020217040747A patent/KR20220009416A/ko unknown
- 2020-05-12 CA CA3140637A patent/CA3140637A1/fr active Pending
- 2020-05-12 BR BR112021022876A patent/BR112021022876A2/pt unknown
- 2020-05-12 EA EA202193146A patent/EA202193146A1/ru unknown
- 2020-05-12 EP EP20728876.2A patent/EP3968986A1/fr active Pending
- 2020-05-12 MA MA055958A patent/MA55958A/fr unknown
- 2020-05-15 TW TW109116151A patent/TW202110441A/zh unknown
-
2021
- 2021-11-16 IL IL288165A patent/IL288165A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3140637A1 (fr) | 2020-11-19 |
| EP3968986A1 (fr) | 2022-03-23 |
| WO2020232037A1 (fr) | 2020-11-19 |
| CN113905733A (zh) | 2022-01-07 |
| TW202110441A (zh) | 2021-03-16 |
| AU2020276595A1 (en) | 2021-12-09 |
| BR112021022876A2 (pt) | 2022-04-12 |
| JP2022532734A (ja) | 2022-07-19 |
| IL288165A (en) | 2022-01-01 |
| US20220211684A1 (en) | 2022-07-07 |
| KR20220009416A (ko) | 2022-01-24 |
| MX2021013899A (es) | 2022-02-10 |
| EA202193146A1 (ru) | 2022-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54076A (fr) | 2-amino-n-hétéroaryl-nicotinamides utilisés en tant qu'inhibiteurs de nav1.8 | |
| CO2017012518A2 (es) | Derivados de 2-(feniloxi o feniltio) pirimidina como herbicidas | |
| MA47469A (fr) | Dérivés 2-(3-(1h-benzo[d]imidazol-1-yl)propyl)pipéridin-3-ol et composés similaires en tant q'inhibiteurs prs pour le traitement du cancer | |
| MA46652A (fr) | Polythérapie pour l'inhibition de c3 | |
| MA51232A (fr) | Indane-amines utiles en tant qu'antagonistes de pd-l1 | |
| CL2021002592A1 (es) | Composiciones fungicidas. | |
| MA53924A (fr) | Modulateurs de l'expression d'apol1 | |
| MA51903A (fr) | Formulations d'anticorps b7-h4 | |
| MA45450B1 (fr) | Formulations d'anticorps anti-cd19 | |
| MA47221A1 (fr) | Anticorps monoclonal à pd-l1 | |
| MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
| MA54283A (fr) | Pyrazoles utilisés utilisés comme modulateurs de l'hémoglobine | |
| MA55095A (fr) | Élimination de conservateur de gouttes oculaires | |
| MX2019006861A (es) | Composicion basada en compuestos de tiosulfinato y/o tiosulfonato para su uso en la prevencion de infecciones bacterianas en animales acuaticos. | |
| FR3067592B1 (fr) | Extrait de nœuds d'arbres appartenant au genre pinus comme fongicide | |
| MA39337A1 (fr) | Modulateurs de pyrazines de gpr6 | |
| MA45158A (fr) | Composition pharmaceutique comprenant de l'éteplirsen | |
| FR3097125B1 (fr) | Composition colorante comprenant une association de deux extraits végétaux deLawsonia inermis | |
| MA55958A (fr) | Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida auris | |
| MA51645A (fr) | Modulateurs de l'expression de dnm2 | |
| MA46898A (fr) | Compositions pour la conservation d'organes | |
| MA41809B1 (fr) | Biotine pour le traitement de la sclérose latérale amyotrophique | |
| UY36160A (es) | “3-arilpirazoles herbicidas sustituidos”. | |
| MA52590A (fr) | Méthodes de traitement de la dépression à l'aide d'anticorps il-23 | |
| MA50163A (fr) | Compositions, utilisations et méthodes pour le traitement de l'infertilité et de la sous-fertilité |